AstraZeneca says its COVID shot has market potential despite lower demand
(Reuters) - AstraZeneca's COVID-19 vaccine still has market potential despite an expected global oversupply of shots and delays in the vaccine's appro...
Source: whbl.com
Stay updated with breaking news from Alexander Smithh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - AstraZeneca's COVID-19 vaccine still has market potential despite an expected global oversupply of shots and delays in the vaccine's appro...